Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €164.03 million as of June 11, 2025. Its market cap has decreased by -12.21% in one year.

Market Cap

164.03M

Enterprise Value

204.72M

Revenue

51.39M

Ranking

n/a

PE Ratio

10.35

Stock Price

€8.10

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 164.03M, a decrease of -15.52%. That is a compound annual growth rate of -0.91%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	164.03M	-11.36%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Siemens Healthineers AG	52.01B
Merck KGaA	50.39B
Bayer Aktiengesellschaft	26.02B
Fresenius SE & Co. KGaA	24.74B
Fresenius Medical Care AG	14.71B
Sartorius Aktiengesellschaft	12.90B
Carl Zeiss Meditec AG	5.34B
Fielmann Group AG	4.63B

Market Cap Rankings